1. Home
  2. ATNM vs UCAR Comparison

ATNM vs UCAR Comparison

Compare ATNM & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.00

Market Cap

31.7M

Sector

Health Care

ML Signal

N/A

Logo U Power Limited

UCAR

U Power Limited

HOLD

Current Price

$0.61

Market Cap

35.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
UCAR
Founded
2000
2013
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
31.7M
35.5M
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
ATNM
UCAR
Price
$1.00
$0.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$4.50
$50.00
AVG Volume (30 Days)
166.5K
181.7K
Earning Date
05-06-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
14.17
N/A
EPS
0.71
N/A
Revenue
$90,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.40
N/A
Revenue Growth
11.11
N/A
52 Week Low
$0.74
$0.04
52 Week High
$1.74
$2.78

Technical Indicators

Market Signals
Indicator
ATNM
UCAR
Relative Strength Index (RSI) 55.05 34.94
Support Level $0.98 $0.52
Resistance Level $1.13 $1.66
Average True Range (ATR) 0.06 0.08
MACD -0.00 0.01
Stochastic Oscillator 39.53 33.66

Price Performance

Historical Comparison
ATNM
UCAR

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

Share on Social Networks: